American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

January 14, 2022

Newsletter Sponsor

Inactivated SARS-CoV-2 Delta Variant

ATCC provides a heat-inactivated preparation of SARS-CoV-2 strain USA/MD-HP05285/2021. This whole-genome sequenced preparation is confirmed to be inviable and non-replicative, making it safe to use in a BSL-1 facility. Explore the use of this product as a process control in the development of SARS-CoV-2 molecular diagnostic tools or for making a dilution series to estimate the level of detection.

	Industry News

Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
Pfizer Inc. and Acuitas Therapeutics have entered into a Development and Option agreement under ... read more »

SaniSure Acquires GL Engineering to Expand its Drug Product Fill and Finish Solutions
SaniSure has acquired GL Engineering (GLE) of East Hanover, New Jersey. read more »

4D Molecular Therapeutics Announces FDA Fast Track Designation Granted to 4D-125 for the Treatment of X-linked Retinitis Pigmentosa
4D Molecular Therapeutics announced that the FDA has granted Fast Track Designation for 4D-125 for ... read more »

Atriva Therapeutics Receives U.S. FDA Orphan Drug Designation for Zapnometinib to Treat Hantavirus Infections
Atriva Therapeutics GmbH has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug ... read more »

	Infographic

Tableting with Coprocessed Excipients
Tableting with Coprocessed Excipients
Explore this infographic that outlines the most important benefits of coprocessed excipients for your tableting process. read more »

	Featured Articles

Changing the Methods Used for Inactivation of Microorganisms and Viruses For many years pharmaceutical companies have relied upon chemical methods to inactivate microorganisms and viruses present in their facilities. Over ... read more »

An Interview with Kaitlyn Vap and Hayden Skalski Biopharmaceutical companies obtain research and development expertise to progress pipeline development projects. While these companies also have ... read more »

	Featured Video

On-Demand Webinar: Microbial Identification in a Manufacturing Environment
In this webinar we will discuss how recent technological developments allow for rapid micro testing and rapid micro identification, focusing on the ... watch »

On-Demand Webinar: A Straightforward Path Toward Regulatory Compliance and Data Integrity with Your Microbial Testing Systems
On-Demand Webinar: A Straightforward Path Toward Regulatory Compliance and Data Integrity with Your Microbial Testing Systems watch »

	Featured Products

4Cell® NutriVero™ Flex 10 Medium
read more »

	Featured Whitepaper

Whitepaper: Analysis of mRNA Vaccines Using UV/Vis Spectrophotometry
Research and development of messenger RNA (mRNA) vaccines relies chiefly on their quality and equivalent action to traditional vaccines, which can be assessed with advanced analytical techniques. UV/... read more »

	Events

PDA Pharmaceutical Microbiology Conference
Washington, DC – 10/10/2022
The 2022 PDA Pharmaceutical Microbiology Conference continues the ongoing tradition of addressing the most relevant opportunities and challenges to ... event details »

Lonza and NNIT to Host Webinar on MES for the Future – Achieving Pharma 4.0 through Accelerated MES Implementation
Online – 01/25/2022
Discover how implementation of next-generation Manufacturing Execution Systems (MES) can be optimized and streamlined to pave the way to faster pharma... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA